Bain Capital Life Sciences Investors, LLC Amylyx Pharmaceuticals, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$17.15 - $30.92 $15.9 Million - $28.6 Million
-925,000 Reduced 47.48%
1,023,214 $28.8 Million
Q2 2022

Aug 15, 2022
SELL
$6.85 - $19.93 $5.53 Million - $16.1 Million
-807,836 Reduced 29.31%
1,948,214 $37.5 Million
Q1 2022

May 16, 2022
BUY
$12.85 - $32.9 $35.4 Million - $90.7 Million
2,756,050 New
2,756,050 $35.4 Million

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $237M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email